The Ministry Of Health Announced The Readiness Of Germany To Produce The Russian Vaccine Against COVID-19

The Ministry Of Health Announced The Readiness Of Germany To Produce The Russian Vaccine Against COVID-19
The Ministry Of Health Announced The Readiness Of Germany To Produce The Russian Vaccine Against COVID-19

Video: The Ministry Of Health Announced The Readiness Of Germany To Produce The Russian Vaccine Against COVID-19

Video: Former FDA chief Scott Gottlieb on Russia's Covid-19 vaccine claims 2022, December
Anonim

German Health Minister Jens Spahn, in a conversation with his Russian counterpart Mikhail Murashko, announced his readiness to produce a Russian vaccine against COVID-19. This is stated in the message of the Ministry of Health of the Russian Federation. Soon, a dialogue will take place between experts of the two countries on the issue of finding the necessary capacities for the joint production of drugs.

Image
Image

“Jens Spahn announced his readiness to cooperate with the Russian Ministry of Health on the issue of attracting German companies for the joint production of Russian vaccines,” the ministry said in a statement.

"In the near future, Russian and German experts will routinely hold negotiations on the search for production facilities for the joint production of Russian vaccines," the department added.

Murashko, the Ministry of Health emphasized, told his colleague about the effectiveness of Russian vaccines and "announced the existence of a special online platform that contains all information about vaccinated individuals."

Russia was the first in the world to register a vaccine against COVID-19. On August 11, the drug Sputnik V was successfully registered. On December 10, an independent committee to evaluate the clinical trials of Sputnik V called the vaccine safe and reported a 96% efficacy. Such high rates after the first vaccination means that it can become one-component.

Later, the British company AstraZeneca agreed to accept the proposal of the creators of Sputnik V to test its vaccine in conjunction with the Russian drug against COVID-19. A recruitment of volunteers aged 18 and over will be open for clinical trials.

Both vaccines are based on adenoviral vectors. According to experts, the combination of the two drugs will bypass possible obstacles to the delivery of information about the coronavirus into the cell and increase the effectiveness of the immune response.]]>

Popular by topic